These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 8230266)
1. Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer. Fornander T; Hellström AC; Moberger B J Natl Cancer Inst; 1993 Nov; 85(22):1850-5. PubMed ID: 8230266 [TBL] [Abstract][Full Text] [Related]
2. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. Fisher B; Costantino JP; Redmond CK; Fisher ER; Wickerham DL; Cronin WM J Natl Cancer Inst; 1994 Apr; 86(7):527-37. PubMed ID: 8133536 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic study of 56 patients with endometrial cancer during or after adjuvant tamoxifen use for their breast cancers. Hachisuga T; Saito T; Kigawa J; Ohwada M; Yamazawa K; Yasue A; Iwasaka T; Sugiyama T; Kita T; Nagai N Gynecol Oncol; 2004 Oct; 95(1):139-44. PubMed ID: 15385123 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. Rutqvist LE; Johansson H; Signomklao T; Johansson U; Fornander T; Wilking N J Natl Cancer Inst; 1995 May; 87(9):645-51. PubMed ID: 7752269 [TBL] [Abstract][Full Text] [Related]
5. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma. Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291 [TBL] [Abstract][Full Text] [Related]
6. Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers. Cook LS; Weiss NS; Schwartz SM; White E; McKnight B; Moore DE; Daling JR J Natl Cancer Inst; 1995 Sep; 87(18):1359-64. PubMed ID: 7658496 [TBL] [Abstract][Full Text] [Related]
7. Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan. Matsuyama Y; Tominaga T; Nomura Y; Koyama H; Kimura M; Sano M; Miura S; Takashima S; Mitsuyama S; Ueo H; Ohashi Y Ann Oncol; 2000 Dec; 11(12):1537-43. PubMed ID: 11205460 [TBL] [Abstract][Full Text] [Related]
8. Endometrial cancer after tamoxifen treatment: a descriptive study of 25 breast cancer patients who subsequently developed endometrial cancer. Peters-Engl C; Medl M; Danmayr E; Mirau M; Alth G; Leodolter S Anticancer Res; 1996; 16(5B):3241-6. PubMed ID: 8920798 [TBL] [Abstract][Full Text] [Related]
9. High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients. Magriples U; Naftolin F; Schwartz PE; Carcangiu ML J Clin Oncol; 1993 Mar; 11(3):485-90. PubMed ID: 8383191 [TBL] [Abstract][Full Text] [Related]
10. Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy. Barakat RR; Gilewski TA; Almadrones L; Saigo PE; Venkatraman E; Hudis C; Hoskins WJ J Clin Oncol; 2000 Oct; 18(20):3459-63. PubMed ID: 11032585 [TBL] [Abstract][Full Text] [Related]
11. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen. Bergman L; Beelen ML; Gallee MP; Hollema H; Benraadt J; van Leeuwen FE Lancet; 2000 Sep; 356(9233):881-7. PubMed ID: 11036892 [TBL] [Abstract][Full Text] [Related]
12. Association between endometrial cancer and tamoxifen treatment of breast cancer. Peters-Engl C; Frank W; Danmayr E; Friedl HP; Leodolter S; Medl M Breast Cancer Res Treat; 1999 Apr; 54(3):255-60. PubMed ID: 10445424 [TBL] [Abstract][Full Text] [Related]
14. Uterine malignancy following tamoxifen use in breast cancer patients in Iran: case series and literature review. Behtash N; Hashemi R; Karimi Zarchi M Asian Pac J Cancer Prev; 2009; 10(1):163-6. PubMed ID: 19469647 [TBL] [Abstract][Full Text] [Related]
15. Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group. Rutqvist LE; Mattsson A J Natl Cancer Inst; 1993 Sep; 85(17):1398-406. PubMed ID: 8350363 [TBL] [Abstract][Full Text] [Related]
16. The nature of tamoxifen action in the control of female breast cancer. Kodama M; Kodama T In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224 [TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological features of endometrial carcinoma in tamoxifen- and toremifene-treated breast cancer patients]. Otsuka I; Takahashi S; O'uchi K; Akimoto N; Hanari K; Ogaki Y; Enatsu YH; Takigawa A; Takaya H; Tanaka A; Kaseki H; Yamada T Gan To Kagaku Ryoho; 2010 Feb; 37(2):279-83. PubMed ID: 20154485 [TBL] [Abstract][Full Text] [Related]
18. Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries. Jones ME; van Leeuwen FE; Hoogendoorn WE; Mourits MJ; Hollema H; van Boven H; Press MF; Bernstein L; Swerdlow AJ Breast Cancer Res; 2012 Jun; 14(3):R91. PubMed ID: 22691381 [TBL] [Abstract][Full Text] [Related]
19. Endometrial adenosarcoma with adjuvant tamoxifen therapy for primary breast carcinoma. Jagavkar RS; Shakespeare TP; Stevens MJ Australas Radiol; 1998 May; 42(2):157-8. PubMed ID: 9599835 [No Abstract] [Full Text] [Related]
20. Relationship between tamoxifen use and high risk endometrial cancer histologic types. Bland AE; Calingaert B; Secord AA; Lee PS; Valea FA; Berchuck A; Soper JT; Havrilesky L Gynecol Oncol; 2009 Jan; 112(1):150-4. PubMed ID: 18937966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]